INSIGHTS ON FACILITY DESIGN

  • Three Options To Viral Vector Manufacturing Capacity

    Industry thought leaders working in the viral vector manufacturing space recently participated in a Virtual Think Tank (VTT), a unique thought leadership platform that brings together leading minds, to discuss viral vector manufacturing facility design. The focus of the most recent VTT was on the current challenges and trends influencing design considerations for viral vector manufacturing facilities and how they can impact companies developing cell and gene therapies.

  • What You Need To Know Before Investing In A Bioprocessing Space

    Selecting the bioreactor that is best for your process and the dedicated space you have available requires consideration of many important factors.

  • 6 Misconceptions About Automating Cell Therapy Manufacturing

    To help you move into a digitized world, here are six common misconceptions that can potentially hinder your ability to successfully execute an MES for cell therapy.

  • Never To Early To Plan For Automation

    Your automation strategy can be designed to expand with your business if you consider your choices in the initial stages. Early platform design selections can greatly affect your future flexibility and ability to show compliance throughout regulatory reviews.

  • Standardization Is Key To Building A Successful Global Business Strategy

    Standardized approaches to biomanufacturing can lower costs, improve outcomes and alter the landscape of the global pharmaceutical market.

  • The Insource Vs. Outsource Dilemma

    Prior to making critical capacity decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best strategy for their manufacturing. Discover the critical elements of this analysis that may help to balance your assessment.

  • Making Data Work

    What is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.

  • When Clean Is Critical—Understanding Parameters And Definitions Of Clean

    Clean room environments necessitate high-quality materials and equipment that conform to a variety of specified standards. This white paper explains how clean parameters are defined and validated.

  • Flexible Manufacturing: Better, Faster Virus Production

    The global vaccine market is growing due to population growth, emerging pathogens and pandemics. The increased demand has led to new vaccines, manufacturing facility projects and increasing investments. Using flexible manufacturing strategies can help meet this growing vaccine demand.

FACILITY DESIGN SOLUTIONS

  • Ibex™ Dedicate

    As the biopharma industry identifies faster and more efficient ways to deliver drugs to patients, such as break-through and fast track designations for accelerated approval, these progresses create pressure on both large and small drug manufacturers. As development timelines shorten, decisions related to drug commercialization need to be taken earlier, when key results are not yet available. And deciding on the scale and type of facility to build without complete data can create substantial risks with costly consequences.

  • GE Life Sciences Overview - Cell Processing

    Helping your cell therapies succeed through our reach and resources.

  • Genderless AseptiQuik® L Series Connectors

    Genderless AseptiQuik® Large Format 3/4", 1" and 1½" sanitary Connectors enable quick and easy sterile connections, even in non-sterile environments. The easy-to-use genderless design simplifies system integration and minimizes the risk of operator error. The connector's robust construction provides enhanced user confidence and reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from a full range of interchangeable 3/4" to 1½" flow solutions for production environments with the quality and market availability they expect from the leader in single-use connection technology.

  • Transformations In Biomanufacturing

    In biomanufacturing the only certainty is risk and the only constant is change. Technology is pushing new frontiers, new markets are opening up across the globe, and new competition is creating new levels of urgency—all under the ever more watchful eye of regulators.

  • Genderless AseptiQuik® L Series Connectors Datasheet

    Genderless AseptiQuik® L Connectors enable quick and easy sterile connections, in large-volume, high-flow production environments. The largeformat, 3/4" and 1" genderless design simplifies system integration and minimizes the risk of operator error.